Affordable, Reliable and Accessible.
The MediCann ecosystem consists of:
- MediCann Clinics - offering both face-to-face and telehealth services. Over 7500 patients have been seen to date with the ability to scale.
- Medicinal product range - 16 different medicines that we supply around Australia through the Maali, BOB and Ananda brands.
- Over the counter hemp foods, skincare, petcare and wellness product range under the brands Hemp Brothers and EndoScent which consist of 20+ products.
- Licenced hemp farm conducting trials and strain development
- B2B white-labelling service for multiple hemp companies in Australia
Business Model
Summary
MediCann has built an integrated cannabis ecosystem consisting of a diversified group of cannabis and hemp brands and services, including medical consultations, medicines and over-the-counter food and wellness products.
Description
We develop and supply cannabis medicines with over 15 different medicines in our existing range. These include a range of unique cannabinoid and terpene formulas in various delivery mechanisms such as oils, flowers, capsules, topicals and vape cartridges.
Along with having our own medicines, we improve patient access through our medical clinic, MediCann Clinics. Our team of doctors and nurses conduct appointments for patients Australia-wide.
We are also in the hemp food and wellness space through our brands Hemp Brothers and EndoScent generating revenue and awareness.
Mission & Objectives
Mission
Our mission is to improve the quality of life for people in need using reliable and affordable cannabis products.
Business Objectives
Short term/medium term objectives:
- Continue to scale and prepare for the next high-growth phase
- Launch our new THC oils and vape cartridges
- Complete product testing and launch CBN and THCV range
- Continue trials on concussion, the next step is the observational trials on humans
- Trials on Motor Neurone Disease and Parkinson's Disease started
- Set up MediCann Dispensary
Long Term
- Completion of clinical trials and product registration which will allow for the potential for subsidies/PBS and global licensing of IP
- Continue to improve the quality of life of people in need
Industry
Summary
The global medicinal cannabis market has rapidly expanded in recent years, with medicinal cannabis now legalised in over 50 countries. It is estimated that the global medicinal cannabis market will be worth $127 Billion by 2028 with CAGR Value of 26%.
Description
Australia is becoming a world leader as both a developer and consumer of medicinal cannabis.
- Australia was the 2nd fastest country in the world to reach 100,000 medical cannabis patients
- 2023 forecast of over $1.4B in sales in Australia compared to $420M in 2022
- By 2030 approximately 670,000 patients may be seeking access to medicinal cannabis in Australia
- There are now up to 4600 Authorised Prescribers of medicinal cannabis in Australia, up from 50 in 2020
- The cannabis industry in Australia is booming and MediCann is placed to continue to take advantage of this.
